Centessa Pharmaceuticals plc Litigation

Sep 2, 2024

No Appeal- Closed

Aug 2, 2024

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Jun 7, 2023

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Feb 15, 2023

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Centessa Pharmaceuticals plc. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Dec 12, 2022

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Sep 28, 2022

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Centessa Pharmaceuticals plc.